Trending Now Biotech

Happy Friday! Today's top biotech news features the 'Effects of Mutations on Protein-Protein Interactions Predicted by New AI Tool' In humans, hundreds of proteins interact in a complex network dubbed the interactome. Those interactions are further complicated when disease-causing mutations are introduced into genes that code for these proteins. Check out the full story 👉 https://zurl.co/wHoG (Genetic Engineering & Biotechnology News) #biotech #mutation

Biotech provides you with today's top trending news 🧬 Novel Group of Bacterial Toxins Take on Fight Against Antibiotic Resistance Antibiotic resistance is a growing concern. According to the Centers for Disease Control and Prevention, more than 2.8 million antimicrobial-resistant infections occur each year. Check out the full article 👉 https://zurl.co/U15b (Genetic Engineering & Biotechnology News) #biotech

Biotech's article of the day features - rADCs Could Take Cancer Treatment ‘Magic Bullet’ to a New Level 💉 Pharmaceutical companies are combining antibodies with radioisotopes in a bid to more precisely deliver radiation to cancers and tumors. Radiation treatments for cancer often come with side effects like fatigue, hair loss, nausea and skin irritation because as the waves traverse through the body, they... Check out the full article 👉 https://zurl.co/Gy1h (BioSpace) #biotech #cancer

Today's top biotech article features - Neurodegeneration could be countered via activation of neural stem cells 🧬 Neural stem cells (NSCs) are important for the development and regeneration of the nervous system... Check out the full article 👉 https://zurl.co/A3Rn (Genetic Engineering & Biotechnology News) #biotech #genetics

Breakthrough Alzheimer's Drug Targets Key 'Hotspots' to Suppress Toxic Tangles. Brains affected by Alzheimer's disease are characterized by damaging clumps and tangles that interfere with neurons – but a new study describes a drug that could potentially suppress half the problem. The drug is RI-AG03, and it's a peptide inhibitor (a blocker of proteins). In tests on fruit flies and human cells, it has shown a positive effect in reducing neuron... Check out the full story 👉 https://zurl.co/pTQF (ScienceAlert) #biotech #genetics

Human Stem Cells Repair Retinas in Monkey Models of Macular Holes. Transplanted human stem cells successfully repaired macular holes in monkey models of the disorder. This is according to a new study from researchers at the Center for Biosystems Dynamics Research at RIKEN, Kober City Eye Hospital, and colleagues at other institutions. Their findings are described in a paper published in... Check out the full story 👉 https://zurl.co/Fq4N (Genetic Engineering & Biotechnology News) #biotech #genetics

Biogen, UCB report phase 3 lupus win, justifying risky bet on asset that failed earlier trial. Biogen and UCB plan to move patients in the existing trial into a long-term open-label study and start a second phase 3. Biogen and UCB’s gamble on advancing into phase 3 on the back of a failed study looks to have paid off, with the partners reporting positive top-line results in systemic lupus erythematosus (SLE) and outlining plans to start a second pivotal trial... Check out the full story 👉 https://zurl.co/2r7J (Fierce Biotech) #biotech #genetics

Just One Shot of an Existing Vaccine Could Prevent Mpox Infection. Mpox (formerly known as monkeypox) is a viral infection that can be prevented with just a single dose of an existing vaccine, a new study finds. This discovery could help slow the tide of the global mpox outbreak, which was declared a public health emergency of international concern by the World Health Organization back in July 2022... Check out the full story 👉 https://zurl.co/Z4sA (ScienceAlert) #biotech #genetics

Sanofi pays $110M upfront for late-stage radioligand therapy, setting up rivalry with Novartis. Sanofi has made a late entry to the radioligand party, paying 100 million euros ($110 million) upfront for global rights to a neuroendocrine tumor treatment that is nearing a filing for approval. The French drugmaker has stayed on the sidelines as a who’s who of drugmakers, led by Novartis, have placed big bets on radioligand therapies. Sanofi is entering the sector through a deal with Radiomedix, Inc. and Orano Med for a targeted alpha... Check out the full story 👉 https://zurl.co/iia1 (Fierce Biotech) #biotech #genetics

Marinomed Biotech AG: First Carragelose products receive new Medical Device Regulation (MDR) certification. Two Carragelose nasal sprays have received declaration of conformity under the new medical device regulation – certificates for further products expected later in the year. Extensive clinical data for Carragelose facilitates challenging demands for MDR transition... Check out the full story 👉 https://zurl.co/MYkF (EQS Group) #biotech #genetics